Sponsor: Grayken Center for Addiction TTA; a program of Boston Medical Center
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphin
For more information and to register click here
Event Details
- Date:
- October 16, 2024
- Time:
- 10:00 am - 11:00 am
- Location:
- virtual
- Cost:
- free